Cytek Biosciences Cash Flows Other Operating Over Time
| CTKB Stock | USD 6.42 0.21 3.38% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cytek Biosciences Performance and Cytek Biosciences Correlation. Cytek |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytek Biosciences. If investors know Cytek will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytek Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.658 | Earnings Share (0.08) | Revenue Per Share 1.527 | Quarterly Revenue Growth 0.073 | Return On Assets (0.03) |
The market value of Cytek Biosciences is measured differently than its book value, which is the value of Cytek that is recorded on the company's balance sheet. Investors also form their own opinion of Cytek Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cytek Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytek Biosciences' market value can be influenced by many factors that don't directly affect Cytek Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytek Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytek Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytek Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash Flows Other Operating Analysis
Compare Cytek Biosciences and related stocks such as Avita Medical, Treace Medical Concepts, and Inogen Inc Cash Flows Other Operating Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RCEL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| TMCI | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | (2.4 M) | 9.3 M | 10.7 M | 11.2 M |
| INGN | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | 1.6 M | 13.2 M | 13.3 M | 17.9 M | 19.3 M | 16.5 M | 6.8 M | 27.8 M | 31.9 M | 33.5 M |
| APYX | 700 K | 700 K | (866 K) | (406 K) | 693 K | 514 K | 444 K | 1.2 M | 63 M | (274 K) | (6.7 M) | 1.5 M | (188 K) | (216.2 K) | (205.4 K) |
Cytek Biosciences and related stocks such as Avita Medical, Treace Medical Concepts, and Inogen Inc Cash Flows Other Operating description
My Equities
My Current Equities and Potential Positions
Check out Cytek Biosciences Performance and Cytek Biosciences Correlation. For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Cytek Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.